Company intelligence / Profile preview

NexPoint Life Sciences III DST

Woodbury, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

NexPoint Life Sciences III DST is a Delaware statutory trust formed by NexPoint to raise approximately $31 million from accredited investors to own a single-tenant life sciences industrial manufacturing and R&D property in Woodbury, Minnesota, leased on a triple-net basis to CDMO Kindeva Drug Delivery.[3][5][15]

Industry: Investors

Partnerships

Kindeva Drug Delivery (single-tenant, long-term triple-net lease at the Woodbury, Minnesota life sciences manufacturing and R&D facility)[3][5][15]

Beyond the preview

Go deeper on NexPoint Life Sciences III DST.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NexPoint Life Sciences III DST.

Explore the full profile